Identification of novel series of pyrazole and indole-urea based DFG-out PYK2 inhibitors.
Bhattacharya, S.K., Aspnes, G.E., Bagley, S.W., Boehm, M., Brosius, A.D., Buckbinder, L., Chang, J.S., Dibrino, J., Eng, H., Frederick, K.S., Griffith, D.A., Griffor, M.C., Guimaraes, C.R., Guzman-Perez, A., Han, S., Kalgutkar, A.S., Klug-McLeod, J., Garcia-Irizarry, C., Li, J., Lippa, B., Price, D.A., Southers, J.A., Walker, D.P., Wei, L., Xiao, J., Zawistoski, M.P., Zhao, X.(2012) Bioorg Med Chem Lett 22: 7523-7529
- PubMed: 23153798 
- DOI: https://doi.org/10.1016/j.bmcl.2012.10.039
- Primary Citation of Related Structures:  
4H1J, 4H1M - PubMed Abstract: 
Previous drug discovery efforts identified classical PYK2 kinase inhibitors such as 2 and 3 that possess selectivity for PYK2 over its intra-family isoform FAK. Efforts to identify more kinome-selective chemical matter that stabilize a DFG-out conformation of the enzyme are described herein ...